Aldeyra Therapeutics, Inc.ALDXNASDAQ
Loading
Debt to Equity Over TimeElevated
Percentile Rank100
3Y CAGR+48.8%
5Y CAGR+6.4%
Year-over-Year Change
Debt-to-equity ratio
3Y CAGR
+48.8%/yr
Annual compound
5Y CAGR
+6.4%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
1.4x
Solid growth
Streak
4 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.35 | +62.8% |
| 2024 | 0.22 | +64.9% |
| 2023 | 0.13 | +22.7% |
| 2022 | 0.11 | +38.2% |
| 2021 | 0.08 | -70.1% |
| 2020 | 0.26 | -16.1% |
| 2019 | 0.31 | - |
| 2018 | 0.00 | -100.0% |
| 2017 | 0.03 | -44.5% |
| 2016 | 0.06 | - |